Decision Biomarkers Inc Announces Formation of Scientific Advi... ( WALTHAM Mass. Dec. 2 /- Decision Biom...)

Decision Biomarkers Inc Announces Formation of Scientific Advisory Board

Date:12/2/2008

WALTHAM, Mass., Dec. 2 /PRNewswire/ -- Decision Biomarkers Inc, a leading developer of protein biomarker analysis systems for pharmaceutical research and development, today announced the formation of a Scientific Advisory Board consisting of internationally renowned scientists and physicians at the forefront of biomarker and clinical research. The Scientific Advisory Board includes:

-- Daniel W. Chan, Ph.D., Director of the Center for Biomarker Discovery and Director, Clinical Chemistry Division, at Johns Hopkins Medical Institution. In addition to his responsibilities of heading the hospital clinical chemistry laboratory, Dr. Chan conducts cutting edge research using state of the art proteomic techniques for biomarker discovery. His overall goals are the identification and characterization of novel biomarkers for the diagnosis and treatment of cancer.

-- Johann de Bono, M.D., Ph.D., Senior Lecturer at The Institute for Cancer Research, Royal Marsden Hospital. Dr. de Bono is leader of the Prostate Cancer Team and directs the clinical drug development Phase I trials program at Royal Marsden Hospital, with a particular interest in pharmacokinetic - pharmacodynamic evaluation of targeted therapeutics.

-- John Heymach, M.D., Ph.D., Assistant Professor of Thoracic Head/Neck Medical Oncology at the University of Texas MD Anderson Cancer Center. The goal of Dr. Heymach's clinical, translational and laboratory research is to advance the development of targeted agents, particularly angiogenesis inhibitors for non-small lung cancer, by incorporating biomarkers into clinical trials to improve patient outcomes.

-- Peter Maimonis, Ph.D. Vice President of Biological Research, Decision Biomarkers, Waltham, MA. Dr. Maimonis has been involved in the discovery and validation of tumor biomarkers for over 20 years. His research has focused on diagnostic markers for breast and colorectal cancer.
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Consumer Advocates Praise Interstate Stem Cell Open Meeting Decision
2. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
3. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
4. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
5. New Data Reveal Ethnicity May Play Role in Weight Loss Decisions
6. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
7. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
8. Scientists Using Social Media to Inform Lab Purchasing Decisions
9. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
10. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
11. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age

Post Your Comments:

Decision Biomarkers Inc Announces Formation of Scientific Advi...( WALTHAM Mass. Dec. 2 /- Decision Biom...)